Formulation: 25 mM HEPES, pH 8.0, with 150 mM sodium chloride, 3 mM DTT, 0.05% polysorbate 20, and 25% glycerol

Purity: ≥80% estimated by SDS-PAGE

• SK1
• SPHK1

Formulation: 45 mM Tris, pH 8.0, with 125 mM sodium chloride, 2.4 mM potassium chloride, 0.045% Tween 20, 50-500 mM imidazole, and 10% glycerol

Purity: ≥90% estimated by SDS-PAGE

• JTK1
• Non-receptor Tyrosine Protein Kinase
• Tyrosine Kinase 2

Formulation: 50 mM HEPES, pH 8.0, with 150 mM sodium chloride, and 20% glycerol

Purity: ≥50% estimated by SDS-PAGE

• NAK
• NF-κB-Activating Kinase
• TANK-Binding Kinase 1

Formulation: 50 mM HEPES, pH 8.0, with 150 mM sodium chloride, 1 mM DTT, and 10% glycerol

Purity: ≥95% estimated by SDS-PAGE

• PKBα
• Protein Kinase Bα
• RAC-α Serine/threonine-protein Kinase
• RAC-PK-α

Formulation: Lyophilized from sterile PBS, pH 7.4, with 5% trehalose, 5% mannitol, and 0.01% Tween-80

Purity: ≥95% estimated by SDS-PAGE

• Activin Receptor-like Kinase 7
• Activin Receptor Type-1C
• ACVR1C

Formulation: Lyophilized from sterile PBS, pH 7.4

Purity: ≥90% estimated by SDS-PAGE

• CD340
• Erb-B2 Receptor Tyrosine Kinase 2
• Human Epidermal Growth Factor Receptor 2
• Neu
• Receptor Tyrosine-Protein Kinase ErbB-2

Formulation: Lyophilized from sterile PBS, pH 7.4

Purity: ≥97% estimated by SDS-PAGE

• Epidermal Growth Factor Receptor
• ErbB-1
• HER1

Formulation: 50 mM Sodium phosphate, pH 7.0, with 300 mM sodium chloride, 150 mM imidazole, 0.25 mM DTT, and 25% glycerol

Purity: ≥90% estimated by SDS-PAGE

• AMPK Subunit α-1
• MGC33776
• MGC57364
• PRKAA1
• AMPK Subunit β-1
• HAMPKb
• MGC17785
• PRKAB1
• AMPK Subunit γ-1
• AMPKG
• MGC8666
• PRKAG1

Formulation: 25 mM HEPES, pH 8.0, with 150 mM sodium chloride, 3 mM DTT, 0.05% Triton X-100, and 5% glycerol

Purity: ≥75% estimated by SDS-PAGE

• SK2
• SPHK2
• SPK2

Formulation: Active recombinant human GST-tagged, His-tagged GSK3β expressed in insect cells

Purity: ≥90% estimated by SDS-PAGE

• Glycogen Synthase Kinase 3β
• GSK3B
• Serine/threonine-protein Kinase GSK3B

Formulation: 40 mM Tris-HCl, pH 8.0, with 110 mM sodium chloride, 2.2 mM potassium chloride, 3 mM DTT, and 20% glycerol

Purity: ≥93% estimated by SDS-PAGE

• TAK1:
• MAP3K7
• TGF1a
• TGFβ-activated Kinase 1
• Mitogen-activated Protein Kinase Kinase Kinase 7
• Transforming Growth Factor-β-activated Kinase 1
• TGF-β-activated Kinase 1
• TAB1:
• MAP3K7IP1
• TAK1-binding Protein 1
• TGF-β-activated Kinase 1 and MAP3K7-binding Protein 1
• Mitogen-activated Protein Kinase Kinase Kinase 7-interacting Protein 1

Formulation: 40 mM Tris-HCl, pH 8.0, with 110 mM NaCl, 2.2 mM KCl, 200 mM imidazole, 20% glycerol, and 3 mM DTT

Purity: ≥90% estimated by SDS-PAGE

• CTHBP
• Cytosolic Thyroid Hormone-binding Protein
• OIP3
• Opa-interacting Protein 3
• Pyruvate Kinase Muscle 2
• THBP1
• Thyroid Hormone-binding Protein 1

Formulation: Lyophilized from sterile 40 mM Tris-HCl, pH 8.0, with 110 mM sodium chloride, 2.2 mM potassium chloride, 3 mM DTT, 0.04% Tween 20, and 20% glycerol

Purity: ≥71% estimated by SDS-PAGE

• Janus-Associated Kinase 2
• JTK10
• Tyrosine-protein Kinase JAK2

Formulation: 50 mM Tris-HCl, pH 7.5, with 200 mM sodium chloride, 20% glycerol, and 1 mM DTT

Purity: ≥90% estimated by SDS-PAGE

• IL-1 Receptor-associated Kinase 4
• Interleukin-1 Receptor-associated Kinase 4
• Renal Carcinoma Antigen NY-REN-64

Formulation: Lyophilized from sterile 40 mM Tris-HCl, pH 8.0, with 110 mM sodium chloride, 2.2 mM potassium chloride, 0.04% Tween 20, 3 mM DTT, 20% glycerol, and 1.6 mM glutathione

Purity: ≥80% estimated by SDS-PAGE

• PKCA
• PKC-A
• PRKCA
• Protein Kinase C Alpha Type

Formulation: 25 mM Tris-HCl, pH 8.0, with 69 mM sodium chloride, 1.35 mM potassium chloride, 0.025% Tween-20, 125 mM imidazole, 50% glycerol, and 3 mM DTT

Purity: ≥60% as determined by SDS-PAGE

• Proto-oncogene Tyrosine-protein Kinase Src
• Proto-oncogene c-Src
• pp60c-src
• p60-Src
• c-SRC

Formulation: 40 mM Tris-HCl, pH 8.0, with 110 mM sodium chloride, 2.2 mM potassium chloride, 0.04% polysorbate 20, and 20% glycerol

Purity: ≥90% estimated by SDS-PAGE

• Janus-Associated Kinase 1
• JTK3
• Tyrosine-Protein Kinase JAK1

Formulation: Lyophilized from sterile PBS, pH 7.4, with 5% trehalose and 5% mannitol

Purity: ≥92% estimated by SDS-PAGE

• Activin Receptor-like Kinase 4
• Activin Receptor Type-1B
• ACTR1B
• ACVR1B
• ACVRLK4
• Serine/threonine-protein Kinase Receptor R2
• SKR2

Formulation: 20 mM HEPES, pH 7.5, with 150 mM sodium chloride, 1 mM DTT, and 5% gylcerol

Purity: ≥90% estimated by SDS-PAGE

• p160 ROCK1
• Renal Carcinoma Antigen NY-REN-35
• Rho-associated, Coiled-coil-containing Protein Kinase 1
• Rho-associated Protein Kinase 1

Formulation: 40 mM Tris-HCl, pH 8.0, 300 mM sodium chloride, 2.2 mM potassium chloride, 20% glycerol, and 0.2 mM TCEP

Purity: ≥90% estimated by SDS-PAGE

• Janus-Associated Kinase 2
• JTK10
• Tyrosine-Protein Kinase JAK2

Formulation: 50 mM potassium phosphate, pH 7.5, with 250 mM potassium chloride, 800 mM lysine, 5% glycerol, and 20 mM DTT

Purity: ≥85% estimated by SDS-PAGE

• PDH Kinase 1
• Pyruvate Dehydrogenase (acetyl-transferring) Kinase Isozyme 1
• Pyruvate Dehydrogenase Kinase Isoform 1

Formulation: 40 mM Tris-HCl, pH 8.0, with 110 mM sodium chloride, 2.2 mM potassium chloride, 3 mM DTT, 20% glycerol, and 200 mM imidazole

Purity: ≥90% estimated by SDS-PAGE

• Janus-Associated Kinase 3
• Leukocyte Janus Kinase
• L-JAK
• Tyrosine-protein Kinase JAK3

Formulation: Lyophilized from sterile PBS, pH 7.4, with 5% Trehalose, 5% Mannitol, and 0.01% Tween-80

Purity: ≥90% estimated by SDS-PAGE

• CD140 Antigen-like Family Member B
• PDGFR-1
• Platelet-derived Growth Factor Receptor 1
• Platelet-derived Growth Factor Receptor β

Formulation: 20 mM HEPES, pH 7.4, with 150 mM sodium chloride and 1 mM DTT

Purity: ≥95%

• KIAA0619
• Rho-associated Coiled-coil-containing Protein Kinase 2
• Rho-associated Protein Kinase 2
• Rho Kinase 2
• p164 ROCK2

Formulation: Lyophilized from sterile PBS, pH 7.4

Purity: ≥85% estimated by SDS-PAGE

• Activin Receptor-like Kinase 5
• Serine/threonine Protein Kinase Receptor 4
• SKR4
• TGF-βRI
• Transforming Growth Factor β Receptor Type I